Seller record · readyrx.com

ReadyRx

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The terms, the product answers and the privacy policy stop at independent, third-party licensed pharmacies and FDA-registered compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

ReadyRxreadyrx.com

6/8criteria passed
Price
Semaglutide $179 first month (sale; regular $249)
Sells
compounded semaglutide, compounded tirzepatide, brand Ozempic, and 6 more
FDA letters
None on file
Visit ReadyRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, brand Ozempic and Zepbound, and sermorelin, NAD+ and glutathione injections and sprays. Every product prints a first-month price below a struck regular price, and no filling pharmacy is named.

Operating entity Ready Health Ventures Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSreadyrx.com, app.readyrx.com/terms
S2Prescription gatingPASSapp.readyrx.com/f/wl/se
S3Pharmacy identificationFAILapp.readyrx.com/terms, readyrx.com/treatments/se
S4Compounding disclosurePASSreadyrx.com/treatments/se, readyrx.com/treatments/ti
S5Analytical documentationFAILreadyrx.com/treatments/se
S6Business addressPASSapp.readyrx.com/privacy
S7Price disclosurePASSreadyrx.com/treatments/se, readyrx.com/treatments/ti, readyrx.com/treatments/ser
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery treatment plan is reviewed and guided by licensed, board-certified clinicians, and the terms state that all clinical decisions are made by independent licensed physicians in third-party medical groups.Source: readyrx.com, app.readyrx.com/terms.
S2PASSEvery start button opens a weight loss or longevity evaluation that begins with the buyer's goals and health history, and no cart exists on the storefront.Source: app.readyrx.com/f/wl/se.
S3FAILThe site names no filling pharmacy. The terms, the product answers and the privacy policy stop at independent, third-party licensed pharmacies and FDA-registered compounding pharmacies.Source: app.readyrx.com/terms, readyrx.com/treatments/se.
S4PASSCompounded personalized GLP-1 medications are not approved by the FDA, printed in the safety answer on the GLP-1 product pages, though the sermorelin and NAD+ pages carry no such statement.Source: readyrx.com/treatments/se, readyrx.com/treatments/ti.
S5FAILAlways lab tested for quality and consistency is a claim with no document behind it. No certificate or lot report is reachable from any product page or the terms.Source: readyrx.com/treatments/se.
S6PASSReady Health Ventures Inc. at 1712 Pioneer Ave Ste 115, Cheyenne, WY 82001, printed in the privacy policy and on no other page.Source: app.readyrx.com/privacy.
S7PASSSemaglutide from $179 for the first month on a quarterly plan and $199 a month after, shown against a struck regular $249; the monthly plan is $229 for the first month and $249 a month after. Tirzepatide is from $255 for the first month against a struck $315, and sermorelin from $155 against a struck $225.Source: readyrx.com/treatments/se, readyrx.com/treatments/ti, readyrx.com/treatments/ser.
S8PASSNo FDA warning letter names ReadyRx or the operating entity Ready Health Ventures, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand Ozempic, Zepbound, sermorelin injection and tablets, NAD+ injection and nasal spray, glutathione injection and nasal spray, MIC+B12, metformin.

Unpaid link. ReadyRx does not pay the site, and nothing is earned when it is used. Funding.

Visit ReadyRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.